May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
p.Gln200Glu, a Putative Constitutively Active Mutant of Rod Alpha-Transducin in Autosomal Dominant Congenital Stationary Night Blindness
Author Affiliations & Notes
  • A. Gal
    Institute of Human Genetics, Univ Med Ctr Hamburg-Eppendorf, Hamburg, Germany
  • V. Szabo
    Institute Human Genetics, Univ Hospital Hamburg-Eppendorf, Hamburg, Germany
    Department of Ophthalmology, Semmelweis Med University, Budapest, Hungary
  • H.-Jü. Kreienkamp
    Institute Human Genetics, Univ Hospital Hamburg-Eppendorf, Hamburg, Germany
  • T. Rosenberg
    Gordon Norrie Centre for Genetic Eye Diseases, The National Eye Clinic for the Visually Impaired, Hellerup, Denmark
  • Footnotes
    Commercial Relationships A. Gal, None; V. Szabo, None; H. Kreienkamp, None; T. Rosenberg, None.
  • Footnotes
    Support Recognition Award of the Alcon Research Institute, German Academic Exchange Service
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1662. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Gal, V. Szabo, H.-Jü. Kreienkamp, T. Rosenberg; p.Gln200Glu, a Putative Constitutively Active Mutant of Rod Alpha-Transducin in Autosomal Dominant Congenital Stationary Night Blindness. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1662.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: To define the gene defect causing congenital stationary night blindness (CSNB) in a family with an autosomal dominant (ad) form of the trait. CSNB is a non-progressive Mendelian condition resulting from a functional defect of rod photoreceptors. A small number of unique missense mutations in the genes encoding rhodopsin (RHO), cGMP phosphodiesterase beta-subunit (PDE6B), and transducin alpha-subunit (GNAT1) have been reported to cause adCSNB. Two basic mechanisms of opposite nature have been suggested to explain the phenotype. While the RHO and PDE6B mutations result in constitutively active proteins, the only known adCSNB-associated GNAT1 change (p.Gly38Asp) seems to be a loss-of-function mutation.

Methods:: The Danish pedigree analysed consists of 9 family members presenting with typical symptoms of CSNB in three generations. In addition to standard ophthalmologic examination, dynamic visual field measurement, colour vision testing, dark adaptometry, and full-field ERG recording were performed.

Results:: Linkage analysis with markers corresponding to loci that map close to RHO and PDE6B yielded negative lod scores, making it unlikely that these genes are implicated in this family. In two-point analysis, D3S1289, the locus close to GNAT1, gave positive lod scores with Zmax=1.81 at theta=0.00. We identified a novel heterozygous C to G transversion (c.598C>G) in exon 6 of GNAT1 that encodes a p.Gln200Glu substitution (CAG>GAG) in the evolutionarily conserved Switch 2 region of alpha-transducin. The mutation results in loss of a TseI site and we showed that the c.598C>G mutation was present in all affected family members in heterozygous state. The c.598C>G change was absent from 104 alleles of unaffected and unrelated controls. Computer modeling based on the known crystal structure of transducin suggests that the mutant protein exhibits impaired GTPase activity, thereby leading to constitutive activation of phototransduction. This assumption is in line with previously published in vitro activity data for a recombinant mutant protein.

Conclusions:: Our findings support the general observation that inappropriately activating mutants of various members of the rod phototransduction cascade represent the major molecular cause of adCSNB.

Keywords: mutations • photoreceptors • signal transduction 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.